Norbert Hoefgen - Concepedia

Author

Norbert Hoefgen

BioCrea (Germany)

Also Known As

Hoefgen, N., N Hoefgen, N. HOEFGEN, N. Hoefgen, Norbert Hoefgen

Publications

294

Citations

H-Index

Concepts

All Affiliations

BioCrea (Germany)Pfizer (United States)

About

Norbert Hoefgen is an author at BioCrea (Germany) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	169
2	Pharmacology	5	5	169
3	Natural Sciences	3	3	107
4	Biochemistry	3	3	107
5	Chemical Biology	1	1	72

Norbert Hoefgen

Publications

273

Citations

H-Index

Page 1

	Year	Citations
In Vivo Efficacy in Airway Disease Models of N-(3,5-Dichloropyrid-4-yl)-[1-(4-fluorobenzyl)-5-hydroxy-indole-3-yl]-glyoxylic Acid Amide (AWD 12-281), a Selective Phosphodiesterase 4 Inhibitor for Inhaled Administration Hildegard Kuss, Norbert Hoefgen, Sarah Johanssen, Journal of Pharmacology and Experimental Therapeutics	2003	89
Highly Potent, Selective, and Orally Active Phosphodiesterase 10A Inhibitors Michael S. Malamas, Yike Ni, James Erdei, Journal of Medicinal Chemistry Medicinal ChemistryDrug TargetPharmaceutical ScienceBiochemistryMedicine	2011	72
Effect of PDE10A inhibitors on MK-801-induced immobility in the forced swim test Barbara Langen, Rita Dost, Ute Egerland, Psychopharmacology PharmacologyMk-801-induced ImmobilityMedicinePde10a InhibitorsForced Swim Test	2011	36
Novel triazines as potent and selective phosphodiesterase 10A inhibitors Michael S. Malamas, Hans Stange, Rudolf Schindler, Bioorganic & Medicinal Chemistry Letters Inhibitory ActivityMedicinal ChemistryMedicinePharmacotherapyDrug Development	2012	26
Synthesis and structure–activity relationship studies of dihydronaphthyridinediones as a novel structural class of potent and selective PDE7 inhibitors Rainer Gewald, C. RUEGER, Christian Grunwald, Bioorganic & Medicinal Chemistry Letters Novel Structural ClassMedicinal ChemistryBiochemistryNatural SciencesMedicine	2011	18
Development of highly potent phosphodiesterase 10A (PDE10A) inhibitors: Synthesis and in vitro evaluation of 1,8-dipyridinyl- and 1-pyridinyl-substituted imidazo[1,5-a]quinoxalines Sally Wagner, Matthias Scheunemann, Karolin Dipper, European Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryAntiparasitic AgentMedicinePotent Phosphodiesterase 10A	2015	17
Radiosynthesis and biological evaluation of the new PDE10A radioligand [<sup>18</sup>F]AQ28A Sally Wagner, Rodrigo Teodoro, Winnie Deuther‐Conrad, Journal of Labelled Compounds and Radiopharmaceuticals	2016	15

Page 1